Atlas Trials

Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells

Clinical trial NCT01919866 · UNKNOWN

Trial details

NCT number
NCT01919866
Sponsor
University Children's Hospital Tuebingen
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute LeukemiasAplastic AnemiaChildhood Solid Tumor
Start date
2004-03-01
Primary completion
2014-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.